FR-128998

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameFR-128998
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlatelet-activating factor inhibitors
TargetsPlatelet-activating factor
Therapy Area/IndicationsDisseminated Intravascular CoagulationAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFujisawa Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFujisawa Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsDisseminated Intravascular CoagulationAsthma

Other Information

ATC CodeN/A
Related LinksN/A